|
AMRX | Amneal Pharmaceuticals, Inc. |
|
|
AMRX | Amneal Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.15 |
| Leverage | 103.38% |
| Market Cap | $ 2.4B |
| PE | 79.43 |
| Dividend Yield | 0.00% |
| Profit | $ 29.8m |
| Margin | 1.05% |
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.